Raymond James Financial
TECX

Raymond James Financial’s Tectonic Therapeutic TECX Stock Holding History

Raymond James Financial’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.5M Buy
72,674
+8,478
+13% +$249K ﹤0.01% 3332
2026
Q1 		$1.98M Buy
64,196
+9,595
+18% +$236K ﹤0.01% 3366
2025
Q4 		$1.14M Buy
54,601
+2,670
+5% +$49.6K ﹤0.01% 3693
2025
Q3 		$815K Buy
51,931
+30,387
+141% +$627K ﹤0.01% 3815
2025
Q2 		$428K Buy
21,544
+2,809
+15% +$56.9K ﹤0.01% 4099
2025
Q1 		$332K Buy
18,735
+13,796
+279% +$450K ﹤0.01% 4156
2024
Q4 		$228K Buy
+4,939
New +$209K ﹤0.01% 4328

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Raymond James Financial's TECX Position: Q2 2026 in Review

Raymond James Financial increased its Tectonic Therapeutic (TECX) stake by 13% in Q2 2026, buying an estimated $249K and bringing the position to 72,674 shares worth $2.5M. The position accounts for ﹤0.01% of the portfolio, ranked #3332.

Raymond James Financial first reported a position in TECX in Q4 2024 and has held it in 7 quarters since. 122 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Raymond James Financial held 72,674 shares of Tectonic Therapeutic worth $2.5M as of Q2 2026.
  • Raymond James Financial bought 8,478 Tectonic Therapeutic shares in Q2 2026, an estimated $249K.
  • Tectonic Therapeutic made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3332 holding.
  • Raymond James Financial first reported a position in Tectonic Therapeutic in Q4 2024 and has held it in 7 quarters since.
  • 122 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.